Development of Large Hollow Particles for Pulmonary Delivery of Cyclosporine A

被引:2
|
作者
Huang, Yongpeng [1 ]
Tang, Hui [1 ]
Meng, Xiangyan [1 ]
Zhao, Zitong [1 ]
Liu, Yanli [1 ]
Liu, Dongxin [1 ]
Chen, Bo [1 ]
Zou, Zhiyun [1 ]
机构
[1] State Key Lab NBC Protect Civilian, Beijing 102205, Peoples R China
关键词
dry powder inhalations; large hollow particles; hydroxypropyl methylcellulose; spray drying; pulmonary delivery; cyclosporine A; SOLID DISPERSION; DRY POWDERS; NANOPOROUS MICROPARTICLES; L-LEUCINE; FORMULATION; INHALATION; AEROSOLIZATION; IMPACT; PYRAZINAMIDE; EXCIPIENTS;
D O I
10.3390/pharmaceutics15092204
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this study was to prepare large hollow particles (LHPs) by spray drying for pulmonary delivery of cyclosporine A (CsA), using L-Leucine (LEU) and hydroxypropyl methylcellulose (HPMC) as excipients and ammonium bicarbonate (AB) as a porogen. The prepared LHPs were spherical particles composed of both CsA and LEU on the surface and HPMC on the inner layer. The formulation of CsA-LEU-0.8HPMC-AB as typical LHPs showed excellent in vitro aerodynamic performance with a minimum mass median aerodynamic diameter (MMAD) of 1.15 & mu;m. The solubility of CsA-LEU-0.8HPMC-AB was about 5.5-fold higher than that of raw CsA, and the dissolution of CsA-LEU-0.8HPMC-AB suggested that the drug was released within 1 h. The cell viability of the A549 cell line showed that CsA-LEU-0.8HPMC-AB was safe for delivering CsA to the lungs. In addition, inhalation administration of CsA-LEU-0.8HPMC-AB with the Cmax and AUC0-& INFIN; increasing by about 2-fold and 2.8-fold compared with the oral administration of Neoral & REG; could achieve therapeutic drug concentrations with lower systemic exposure and significantly improve the in vivo bioavailability of CsA. From these findings, the LHPs, with the advantage of avoiding alveolar macrophage clearance, could be a viable choice for delivering CsA by inhalation administration relative to oral administration.
引用
收藏
页数:20
相关论文
共 50 条
  • [41] Synthesis of functional hollow WS2 particles with large surface area for Near-Infrared (NIR) triggered drug delivery
    Liu, Na
    Fan, Fan
    Xu, Wei
    Zhang, Hao
    Zhou, Qi
    Li, Xiaopeng
    JOURNAL OF ALLOYS AND COMPOUNDS, 2021, 875
  • [42] An in vitro and in vivo study on the properties of hollow polycaprolactone cell-delivery particles
    Stander, Barend Andre
    van Vollenstee, Fiona A.
    Kallmeyer, Karlien
    Potgieter, Marnie
    Joubert, Annie
    Swanepoel, Andri
    Kotze, Lara
    Moolman, Sean
    Pepper, Michael S.
    PLOS ONE, 2018, 13 (07):
  • [43] Evaluation of novel particles as pulmonary delivery systems for insulin in rats
    Lucila Garcia-Contreras
    Tülin Morçöl
    Steve J. D. Bell
    Anthony J. Hickey
    AAPS PharmSci, 5 (2):
  • [44] TAILORING MACROPHAGE UPTAKE OF INHALED PARTICLES FOR PULMONARY DELIVERY APPLICATIONS
    Shen, T. W.
    Fromen, C. A.
    Roberts, R. A.
    Allen, I. C.
    Luft, J. C.
    Ting, J. P.
    DeSimone, J. M.
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2013, 26 (02) : A11 - A11
  • [45] Formulation and comparison of spray dried non-porous and large porous particles containing meloxicam for pulmonary drug delivery
    Chvatal, Anita
    Ambrus, Rita
    Party, Petra
    Katona, Gabor
    Jojart-Laczkovich, Orsolya
    Szabo-Revesz, Piroska
    Fattal, Elias
    Tsapis, Nicolas
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 559 : 68 - 75
  • [46] DEVELOPMENT AND IN VITRO EVALUATION OF BUDESONIDE SUBMICRON DRUG PARTICLES: AN APPROACH TO IMPROVE LUNGS DEPOSITION AND DISSOLUTION FOR PULMONARY DELIVERY
    Rauf, Abdul
    Ahmad, Niyaz
    Mirza, Mohd Aamir
    Sultana, Shaheen
    Talegaonkar, Sushma
    Iqbal, Zeenat
    Bhatnagar, Aseem
    Khar, Roop K.
    Ahmad, Farhan J.
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2013, 26 (04) : A255 - A255
  • [47] CYCLOSPORINE IN PULMONARY SARCOIDOSIS
    REBUCK, AS
    SANDERS, BR
    MACFADDEN, DK
    MAN, SFP
    YORK, EL
    COHEN, RD
    LANCET, 1987, 1 (8548): : 1486 - 1486
  • [48] Development of cyclodextrin microspheres for pulmonary drug delivery
    Skiba, M
    Bounoure, F
    Barbot, C
    Arnaud, P
    Skiba, M
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2005, 8 (03): : 409 - 418
  • [49] Trojan particles: Large porous carriers of nanoparticles for drug delivery
    Tsapis, N
    Bennett, D
    Jackson, B
    Weitz, DA
    Edwards, DA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (19) : 12001 - 12005
  • [50] Porous particles and novel carrier particles with enhanced penetration for efficient pulmonary delivery of antitubercular drugs
    Tse, Jun Yee
    Koike, Atsushi
    Kadota, Kazunori
    Uchiyama, Hiromasa
    Fujimori, Ko
    Tozuka, Yuichi
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2021, 167 : 116 - 126